Eli Lilly (LLY) Cash from Operations Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
220.11% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-39.77% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
134.19% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
56.72% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
57.37% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
44.79% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
11.99% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-43.50% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
220.11% |
| Dec 31, 2025 |
30.34% |
| Sep 30, 2025 |
138.04% |
| Jun 30, 2025 |
110.51% |
| Mar 31, 2025 |
42.88% |
| Dec 31, 2024 |
892.92% |
| Sep 30, 2024 |
69.53% |
| Jun 30, 2024 |
132.03% |
| Mar 31, 2024 |
-32.62% |
| Dec 31, 2023 |
-118.76% |
| Sep 30, 2023 |
-1.23% |
| Jun 30, 2023 |
-46.60% |
| Mar 31, 2023 |
-31.41% |
| Dec 31, 2022 |
-26.48% |
| Sep 30, 2022 |
35.89% |
| Jun 30, 2022 |
-33.35% |
| Mar 31, 2022 |
48.64% |
| Dec 31, 2021 |
24.60% |
| Sep 30, 2021 |
-9.70% |
| Jun 30, 2021 |
-28.85% |
| Mar 31, 2021 |
343.88% |
| Dec 31, 2020 |
-7.56% |
| Sep 30, 2020 |
19.63% |
| Jun 30, 2020 |
137.32% |
| Mar 31, 2020 |
22.84% |
| Dec 31, 2019 |
35.55% |
| Sep 30, 2019 |
-28.83% |
| Jun 30, 2019 |
-30.71% |
| Mar 31, 2019 |
-28.68% |
| Dec 31, 2018 |
-16.91% |
| Sep 30, 2018 |
12.80% |
| Jun 30, 2018 |
-8.09% |
| Mar 31, 2018 |
28.42% |
| Dec 31, 2017 |
-13.11% |
| Sep 30, 2017 |
13.20% |
| Jun 30, 2017 |
17.78% |
| Mar 31, 2017 |
255.13% |
| Dec 31, 2016 |
101.44% |
| Sep 30, 2016 |
50.42% |
| Jun 30, 2016 |
47.79% |
| Mar 31, 2016 |
-158.37% |
| Dec 31, 2015 |
-30.87% |
| Sep 30, 2015 |
-34.68% |
| Jun 30, 2015 |
-9.99% |
| Mar 31, 2015 |
-131.14% |
| Dec 31, 2014 |
-16.56% |
| Sep 30, 2014 |
-15.08% |
| Jun 30, 2014 |
-35.63% |
| Mar 31, 2014 |
-28.23% |
| Dec 31, 2013 |
7.79% |
| Sep 30, 2013 |
28.96% |
| Jun 30, 2013 |
25.36% |
| Mar 31, 2013 |
-55.50% |
| Dec 31, 2012 |
-17.62% |
| Sep 30, 2012 |
-25.52% |
| Jun 30, 2012 |
-35.99% |
| Mar 31, 2012 |
-27.51% |
| Dec 31, 2011 |
-12.72% |
| Sep 30, 2011 |
17.87% |
| Jun 30, 2011 |
6.73% |
| Mar 31, 2011 |
22.77% |
| Dec 31, 2010 |
10.38% |
| Sep 30, 2010 |
34.72% |
| Jun 30, 2010 |
107.04% |
| Mar 31, 2010 |
989.87% |
